About
Contact
Subscribe
e-Edition

Make Home Page

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter

- Site search

Home
News
Sports
- Local Sports
- National Sports
Business
Opinion
A & E
Life
Features & Magazines
Classifieds
Weather
Obituaries
Parcel Pickup

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

58.59 +0.53 (+0.91%)

Streaming Delayed Price Updated: 12:34 PM EST, Nov 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

42 43 Next >

Exploring the top movers within the S&P500 index during today's session. ↗

March 20, 2025

Curious about the S&P500 stocks that are in motion on Thursday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

Top S&P500 movers in Thursday's session ↗

March 20, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

Nasdaq Sell-Off: 2 Brilliant Stocks to Buy No Matter What the Market Does Next ↗

March 19, 2025

Via The Motley Fool

Dexcom Report Unveiled at ATTD 2025 Reveals HCPs Favour Tech Over Medication for Future of Type 2 Care

March 19, 2025

From DexCom, Inc.

Via Business Wire

DexCom Analysts Increase Their Forecasts After Q4 Earnings ↗

February 14, 2025

Via Benzinga

10 Worst Performing Large-Caps Last 12 Months ↗

March 13, 2025

Here’s this week’s top 10 worst performing Large-Caps in the last twelve months.

Via Talk Markets

Topics Stocks / Equities

Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)

March 11, 2025

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how ResMed (NYSE:RMD) and the rest...

Via StockStory

Topics Artificial Intelligence

Which S&P500 stocks are moving on Monday? ↗

March 10, 2025

Curious about the S&P500 stocks that are in motion on Monday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

Why Dexcom Is On A Six-Day Losing Spree — But This Analyst Isn't Worried ↗

March 10, 2025

The company is facing a regulatory setback. But one analyst doesn't expect that to impact its upcoming, potential approval.

Via Investor's Business Daily

Stay updated with the S&P500 stocks that are on the move in today's pre-market session. ↗

March 10, 2025

Wondering what's happening in today's pre-market session? Stay tuned for the latest updates on S&P500 stock movements.

Via Chartmill

Dexcom Appoints Renée Galá to Board of Directors

March 10, 2025

From DexCom, Inc.

Via Business Wire

DEXCOM INC (NASDAQ:DXCM)—Positioned as a High-Growth Stock, Ready for a Potential Breakout. ↗

March 03, 2025

Based on technical and fundamental analysis of NASDAQ:DXCM we find: DEXCOM INC (NASDAQ:DXCM) qualifies as a high growth stock and is consolidating.

Via Chartmill

3 Growth Stocks to Buy and Hold Forever ↗

March 01, 2025

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

February 27, 2025

Via Benzinga

Dexcom Announces Upcoming Conference Presentation

February 27, 2025

From DexCom, Inc.

Via Business Wire

Reflecting On Patient Monitoring Stocks’ Q4 Earnings: DexCom (NASDAQ:DXCM)

February 27, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how patient monitoring stocks fared in Q4, starting with DexCom...

Via StockStory

Topics Artificial Intelligence

Got $200? 2 Healthcare Stocks to Buy and Hold Forever ↗

February 26, 2025

Via The Motley Fool

These S&P500 stocks are moving in today's pre-market session ↗

February 19, 2025

Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top S&P500 gainers and losers in today's pre-market session.

Via Chartmill

Insulet Earnings: What To Look For From PODD

February 19, 2025

Insulin delivery company Insulet Corporation (NASDAQ:PODD) will be announcing earnings results tomorrow after market close. Here’s what to expect.

Via StockStory

iRhythm (IRTC) To Report Earnings Tomorrow: Here Is What To Expect

February 19, 2025

Medical technology company iRhythm Technologies (NASDAQ:IRTC) will be announcing earnings results tomorrow afternoon. Here’s what investors should know.

Via StockStory

What's going on in today's session: S&P500 movers ↗

February 14, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.

Via Chartmill

Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom ↗

February 14, 2025

DexCom reported Q4 revenue of $1.11 billion, surpassing estimates. The company reaffirmed its 2025 outlook while analysts highlighted long-term growth potential.

Via Benzinga

In today's session, there are S&P500 stocks with remarkable trading volume. ↗

February 14, 2025

Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.

Via Chartmill

Stocks Head For Weekly Gains, US Treasury Yields Fall Below 4.5%: What's Driving Markets Friday? ↗

February 14, 2025

Stocks are headed for weekly gains, with the Dow Jones dipping slightly and the S&P 500 and Nasdaq trading just above the flatline Friday.

Via Benzinga

Topics Stocks

Discover which S&P500 stocks are making waves on Friday. ↗

February 14, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

Dexcom Q4 Earnings: Expanding Sales, New Products, Margin Pressure And More ↗

February 14, 2025

Dexcom reported Q4 results, with revenue up 8%, beating estimates. CEO looks forward to unlocking next wave of global access.

Via Benzinga

DexCom (DXCM) Q4 2024 Earnings Call Transcript ↗

February 13, 2025

DXCM earnings call for the period ending December 31, 2024.

Via The Motley Fool

Topics Earnings

DexCom: Revenue Up, EPS Misses Mark ↗

February 13, 2025

DexCom reported mixed earnings, with revenue surpassing estimates but earnings per share falling short.

Via The Motley Fool

DexCom’s (NASDAQ:DXCM) Q4: Beats On Revenue

February 13, 2025

Medical device company DexCom (NASDAQ:DXCM) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 7.6% year on year to $1.11 billion. The company expects the full year’s...

Via StockStory

Topics Artificial Intelligence

Dexcom Tumbles As Fourth-Quarter Profit Lags Expectations ↗

February 13, 2025

Dexcom stock fell late Thursday after the company missed fourth-quarter profit expectations by a nickel per share.

Via Investor's Business Daily

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

42 43 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Opinion
Photo Galleries
Videos
Local Events
Classifieds
Obituaries

Services

About
Contact
Personnel
Advertise
Subscription Services
Promote Your Event
Dealer Locations
Email Alerts
Submission Forms

Contact Information

chroniclejournal.com
75 S. Cumberland Street
Thunder Bay, ON P7B 1A3
Phone: 807 343 6200
Email: circulation@chroniclejournal.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

DexCom, Inc. - Common Stock (NQ:DXCM)

All News about DexCom, Inc. - Common Stock

Sections

Services

Contact Information

Follow Us